PRF Technologies

PRF Technologies Receivables

The Accounts Receivable of PRF Technologies (PRFX) as of Oct 15, 2026 is 119,000.00 USD. In the previous year, Accounts Receivable was 45,000.00 USD — a change of 164.44% (higher).

Receivables

119,000.00USD

YoY

164.44%

Last updated:

Accounts Receivable of PRF Technologies is 2024 119,000.00 USD. Accounts Receivable of PRF Technologies was 2023 45,000.00 USD. It decreases by 164.44% higher compared to the previous year.

The PRF Technologies Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2017
20,000.00 USD
Jan 1, 2018
30,000.00 USD
Jan 1, 2019
20,000.00 USD
Jan 1, 2020
50,000.00 USD
Jan 1, 2021
220,000.00 USD
Jan 1, 2022
60,000.00 USD
Jan 1, 2023
45,000.00 USD
Jan 1, 2024
119,000.00 USD
The PRF Technologies Receivables history
YEARReceivablesYoY
119,000.00USD+164.44%
45,000.00USD-25.00%
60,000.00USD-72.73%
220,000.00USD+340.00%
50,000.00USD+150.00%
20,000.00USD-33.33%
30,000.00USD+50.00%
20,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PRF Technologies Stock analysis

What does PRF Technologies do? PRF Technologies Ltd, listed under the ticker PRFX with ISIN IL0011651580, is a pharmaceutical company based in Tel Aviv-Yafo, Israel. The company operates within the Health Care sector and has a workforce of six employees. PRF Technologies Ltd. went public on September 1, 2020. Its website is https://painreform.com/. The company focuses on reformulating established therapeutics, particularly in the area of pain management. PRF Technologies Ltd. develops reformulated pain therapeutics designed to prolong efficacy, enhance therapeutic outcomes, minimize adverse effects, and improve patient convenience. The company's technology aims to facilitate a faster return of motor function for patients. The company's activities are centered on leveraging existing pharmaceuticals to create more effective and user-friendly treatments without introducing new active ingredients. PRF Technologies Ltd. is engaged in the development of innovative approaches to pain management, emphasizing the optimization of current therapeutic options. PRF Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PRF Technologies stock

Accounts Receivable of PRF Technologies is 119,000.00 USD in 2024.

Accounts Receivable of PRF Technologies changed from 45,000.00 USD to 119,000.00 USD, representing a 164.44% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable PRF Technologies since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's PRF Technologies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — PRF Technologies

All Key Metrics — PRF Technologies